Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Chang David D
President and CEO at Allogene Therapeutics. Filing since 15 Oct 2018.
CIK 0001611024
Company
Date
Role
Action
Shares
Amount
Of holding
ALLO
Allogene Therapeutics, Inc.
16 Mar 2026
President and CEO
Sold at will
47,763
$117.97K
0.9%
ALLO
Allogene Therapeutics, Inc.
2 Feb 2026
President and CEO
Sold at will
95,269
$171.48K
1.8%
ALLO
Allogene Therapeutics, Inc.
14 Mar 2025
President and CEO
Sold at will
46,668
$91.47K
0.9%
ALLO
Allogene Therapeutics, Inc.
3 Feb 2025
President and CEO
Sold at will
46,003
$77.29K
0.9%
ALLO
Allogene Therapeutics, Inc.
15 Mar 2022
President and CEO
Sold, plan not stated
23,648
$180.88K
1.0%
ALLO
Allogene Therapeutics, Inc.
15 Mar 2021
President and CEO
Sold, plan not stated
20,513
$791.27K
0.9%
ALLO
Allogene Therapeutics, Inc.
16 Mar 2020
President and CEO
Sold, plan not stated
20,335
$392.62K
0.9%
ALLO
Allogene Therapeutics, Inc.
15 Oct 2018
President and CEO
Bought
40,000
$720.00K
2.0%
8 decisions on file.
